Overview

Mirabegron Combined With Behavioral Intervention for Overactive Bladder：a Prospective Multicenter Randomized Controlled Clinical Study

Status:
Not yet recruiting

Trial end date:
2023-07-15

Target enrollment:

Participant gender:

Summary

The purpose of this study was to assess the efficacy, safety and tolerability of Mirabegron and behavioral combination versus Mirabegron alone in the treatment of women with overactive bladder (OAB）.

Phase:

Phase 4

Details

Lead Sponsor:

Peking Union Medical College Hospital

Treatments:

Mirabegron